
QMS Medical Allied Q1 Results FY26: Q1 PAT Rises 22.25% to ₹2.93 Crore; Revenue up 53.11% YoY
Posted by : sachet | Wed Aug 20 2025

QMS Medical Allied Q1 Results FY26: QMS Medical Allied posted its Q1 results on 18th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹22.25 crores against revenue of ₹48.50 crores. During Q1 FY26, the profit increase of the company was recorded at 22.25% YoY, and the revenue increase for the same period was 53.11%.
QMS Medical Allied Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
Particulars | Quarter Ended | |
30-06-2025 | 30-06-2024 | |
Revenue from Operations | ₹46.50 | ₹30.37 |
Profit Before Tax (PBT) | ₹6.76 | ₹4.95 |
Profit After Tax (PAT) | ₹2.93 | ₹2.40 |
(Figures in crores)
QMS Medical Allied Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
Particulars | Quarter Ended | |
30-06-2025 | 30-06-2024 | |
Revenue from Operations | ₹42.32 | ₹30.37 |
Profit Before Tax (PBT) | ₹6.42 | ₹4.95 |
Profit After Tax (PAT) | ₹2.70 | ₹2.40 |
(Figures in crores)
QMS Medical Allied Q1 Results FY26 Highlights (Q1 FY26 vs FY25)
- QMS Medical Allied clocked Q1 FY26 consolidated revenue of ₹46.50 crores vs ₹30.37 crores.
- On the profit front, QMS Medical Allied earned a consolidated PAT of ₹2.93 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹2.40 crore.
- Consolidated PAT rose for the first quarter of FY26, was 22.25% YoY, and revenue rose 53.11% YoY.
- QMS Medical Allied clocked Q1 FY26 standalone revenue of ₹42.32 crores vs ₹30.37 crores.
- On the profit front, QMS Medical Allied earned a standalone PAT of ₹2.70 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹2.40 crore.
- As per the standalone figures, the quarterly PAT of QMS Medical Allied has increased by 12.48%, and revenue has increased by 39.37% YoY.
QMS Medical Allied Share Price Performance
On the opening bell of 20th August 2025, the shares of QMS Medical Allied opened at ₹80.00 per share. However, the initial gains are wiped out as of now, and QMS Medical Allied shares are trading at ₹81.00 per share, lower than their opening price.
Considering the long-term performance, QMS Medical Allied shares have yielded close to -30.53% returns in the past 1 year, and 5-year returns stand at -54.96%. Over the maximum timeframe, the QMS Medical Allied share provided -54.96% returns to investors.
What Analysts Expect Post Q1 Results?
As QMS Medical Allied has posted robust Q1 results for FY26, analysts are expecting positive trends in its share price. As per the analysts, QMS Medical Allied share price could reach ₹100.20 per share in the coming year, and in downtrends, the share price could hit the level of ₹70.10 per share. However, one must ignore the risk of volatility in the stock market and invest in QMS Medical Allied shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Mangal Electrical IPO GMP: Day 1 IPO Live Updates
Indokem Q1 Results FY26: Q1 PAT Falls 150.72% to ₹0.70 Crore; Revenue Up 12.41% YoY
Excel Industries Q1 Results FY26: Q1 PAT Rises 34.90% to ₹33.76 Crore; Revenue Up 16.84% YoY
Shiva Global Q1 Results FY26: Q1 PAT Rises 167.41% to ₹2.42 Crore; Revenue Down 15.99% YoY
DMCC Q1 Results FY26: Q1 PAT Rises 36.60% to ₹7.76 Crore; Revenue Up 48.91% YoY
TGV Q1 Results FY26: Q1 PAT Rises 182.64% to ₹13.71 Crore; Revenue Up 29.51% YoY
Gujarat Alkalies Q1 Results FY26: Q1 PAT Rises 132.00% to ₹21.00 Crore; Revenue Up 13.08% YoY
Related Posts
LGT Business Connextions IPO Subscription, GMP, Details & Reviews
LGT Business Connextions IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Classic Electrodes IPO GMP & Review: Apply or Avoid?
Patel Retail IPO Allotment Status Check Online: GMP, Subscription, Price, and More
P M Telelinks Q1 Results FY26: Q1 PAT Surges 75.00% to -₹0.01 Crore; Revenue Down 28.74% YoY
